NetworkNewsBreaks Archive - Page 2204 of 2212

FridayOct 14, 2016 3:49 pm

Tetraphase Pharmaceuticals, Inc. (TTPH) Doses First Patient in IGNITE4 Clinical Trial

Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) this morning announced that it has dosed the first patient in IGNITE4, the company’s phase 3 clinical trial evaluating the efficacy and safety of intravenous (IV) eravacycline compared to meropenem in complicated intra-abdominal infections (cIAI). Eravacycline is a novel antibiotic candidate with potent activity against multidrug-resistant (MDR) pathogens for the treatment of serious and life-threatening bacterial infections. To view the full press release, visit: http://nnw.fm/RFg2j About Tetraphase Pharmaceuticals, Inc. Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections, including those caused by many…

FridayOct 14, 2016 12:23 pm

Inventergy, Inc. (INVT) Closes Public Offering with Proceeds of $6M, Tops NASDAQ Listing Requirements

Inventergy Global, Inc. (NASDAQ: INVT) shares are up more than 5% in Friday’s mid-morning trade. The company this morning announced the closing of its previously announced common stock and warrant offering for aggregate gross proceeds of $6.0 million. As a result, INVT said its pro forma stockholders' equity exceeds the $2.5 million requirement for continued listing on the Nasdaq exchange. To view the full press release, visit: http://nnw.fm/Y62fR About Inventergy Global, Inc. Inventergy Global, Inc. is a Silicon Valley-based intellectual property company dedicated to identifying, acquiring and licensing patented technologies of market-significant technology leaders. Led by IP industry pioneer and…

FridayOct 14, 2016 12:22 pm

Ocean Power Technologies, Inc. (OPTT) Prices Common Stock Offering of 2.4M Shares

Ocean Power Technologies (NASDAQ: OPTT) has priced an underwritten public offering of 2.4 million shares of its common stock at a price to the public of $2.75 per share. The offering is expected close on or about October 19, 2016. OPTT said it plans to use the proceeds for general corporate purposes, “which may include additional development, testing and demonstrations of its PowerBuoy system with the goal of furthering and accelerating its commercialization efforts and expanding its sales and marketing functions.” Shares are down 23% in late morning trade. To view the full press release, visit: http://nnw.fm/08Rxj About Ocean Power…

FridayOct 14, 2016 12:21 pm

Neonode, Inc. (NEON) Shares Soar on $11M Supply Contract

Shares of Neonode (NASDAQ: NEON) climbed more than 25% in Friday’s morning session after the optical interactive sensing technology company announced an agreement in which it will supply its zForce AIR™ sensor modules to a U.S.-based automotive OEM for vehicle entry systems. The value of the contract exceeds $11 million over its term, which starts in the third quarter of 2017. NEON’s zForce technology, which is currently installed in over 1 million cars, powers the AirBar™ device that enables touch and gesture sensing to PCs and for automotive application. To view the full press release, visit: http://nnw.fm/7svXD About Neonode Neonode…

ThursdayOct 13, 2016 1:35 pm

Midwest Energy Emissions Corp. (MEEC) Trades Higher on Expected Q3 Revenues of $11.7M, Full-Year Guidance

Midwest Energy Emissions (OTCQB: MEEC) this morning issued an operational update and preliminary revenue results for its third quarter ended September 30, 2016, as well as reiterated its revenue guidance for the full year ending December 31, 2016. The company said it expects total third-quarter revenues of more than $11.7 million, an increase of at least 225% when compared to revenue of $3.6 million for the same period last year. For the full year ending December 31, 2016, MEEC reiterated expected revenues of at least $30 million, an increase of at least 137% when compared to revenue of $12.6 million…

ThursdayOct 13, 2016 1:34 pm

OncoGenex Pharmaceuticals, Inc. (OGXI) Down 9% on Disappointing Phase 3 ENSPIRIT Trial Results

OncoGenex Pharmaceuticals (NASDAQ: OGXI) shares slid more than 9% in Thursday’s mid-day trade following the company’s morning announcement that its phase 3 ENSPIRIT trial of custirsen in patients whose non-small cell lung cancer (NSCLC) did not meet the primary endpoint of demonstrating a statistically significant improvement in overall survival for patients treated with custirsen in combination with docetaxel compared to docetaxel alone. Safety results were consistent with those observed in previous trials of custirsen in combination with chemotherapy. To view the full press release, visit: http://nnw.fm/X5x4V About OncoGenex OncoGenex is a biopharmaceutical company committed to the development and commercialization of…

ThursdayOct 13, 2016 1:33 pm

ContraVir Pharmaceuticals, Inc. (CTRV) Soars 21% on Positive Clinical Study of Hepatitis B Candidate

Shares of ContraVir Pharmaceuticals (NASDAQ: CTRV) surged in Thursday’s morning trade after the biopharmaceutical company reported positive interim data for CMX157 from its ongoing phase 2a multiple ascending dose clinical study. The head-to-head study is the first evaluation of CMX157 in patients with hepatitis B (HBV), and directly compares CMX157 to tenofovir disoproxil fumarate (TDF, Gilead's Viread®) in chronically infected HBV patients. The CMX157 treated patients showed an average 99% reduction in HBV viral load compared to baseline. "The significant viral load reduction and favorable safety at this low dose of CMX157 speaks to the unique liver-targeting mechanism of our…

ThursdayOct 13, 2016 1:31 pm

iGambit, Inc. (IGMB) Successes Driven by Top Management

iGambit, Inc. (OTCQB: IGMB) is a diversified holding company focused primarily on the acquisition of early-stage technology firms. The experience and past endeavors of IGMB’s management team bodes well for the company, whose most recent acquisition was named as a ‘Top 20 Enterprise Security Company of 2016’ by leading IT publication CIOReview. IGMB Chairman John Salerno has more than 40 years of experience in the technology industry, while CEO Rory Welch has more than 20 years of senior management in a variety of industries. To view the full article, visit: http://nnw.fm/VzV1N About iGambit Inc. iGambit (OTCQB: IGMB) is a fully…

ThursdayOct 13, 2016 11:37 am

Hybrid Coating Technologies, Inc. (HCTI) in Final Stretch of Discussions with Joint-Development Partner

Hybrid Coating Technologies (OTC: HCTI) this morning announced its “advanced discussions” with an undisclosed partner regarding a joint agreement for the development of a foam product based on Hybrid’s non-isocyanate polyurethane technology. “We are very pleased to be working to finalize an agreement with yet another partner,” Joseph Kristul, HCTI president and CEO, stated in the news release. “In the past twelve months, we have made significant progress including entering into three agreements, launching a product with a fourth partner and entering into final discussions with two additional partners.” HCTI said it expects to enter into an LOI with this…

WednesdayOct 12, 2016 1:53 pm

eXp World Holdings, Inc. (EXPI) Teams with New Story to Provide Housing in Haiti – Exceeds Funding Goals within Hours

eXp Realty, the Agent-Owned Cloud Brokerage® owned by eXp World Holdings, Inc. (OTCQB: EXPI), this morning announced its newly formed partnership with New Story, a non-profit that builds homes in impoverished areas such as Haiti. eXp Realty initially announced the partnership last week during its third annual company convention in San Antonio, Texas. The company challenged its agents and brokers to raise $18,000 to fund the construction of three new homes in Haiti - a goal achieved within three hours of the announcement, raising a total of $35,000 to fund additional construction. To view the full press release, visit: http://nnw.fm/YeSy4…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks